Related Experiment Video
Updated: Mar 6, 2026
09:45
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
8.9K
A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic
Chuangnian Zhang1, Ju Zhang2, Gaona Shi1
1Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College , Tianjin, 300192, China.
Molecular Pharmaceutics
|March 16, 2017
Summary
This study developed light-responsive nanoparticles for cancer immunotherapy. The nanoparticles enhance antigen delivery to T cells, boosting immune response and inhibiting tumor growth.
Area of Science:
- Nanomedicine
- Immunology
- Photodynamic Therapy
Background:
- Cancer immunotherapy requires effective antigen delivery to stimulate T cell responses.
- Photochemical internalization (PCI) offers a method to enhance intracellular drug/antigen delivery.
- Nanoparticle-based systems can improve antigen presentation and immune cell targeting.
Purpose of the Study:
- To develop a light-responsive nanoparticle system for enhanced antigen-specific CD8+ T cell immune response in cancer immunotherapy.
- To utilize photochemical internalization (PCI) to improve antigen delivery and T cell activation.
- To evaluate the efficacy of the nanoparticle system in vitro and in vivo for cancer treatment.
Main Methods:
- Preparation of Pheophorbide A-grafted polyethylenimine (PheoA-PEI) nanoparticles complexed with ovalbumin (OVA).
- Assessment of cellular uptake, reactive oxygen species (ROS) generation, and cytosolic antigen release using flow cytometry and confocal microscopy.
- Evaluation of antigen cross-presentation in vitro and CD8+ T cell response in vivo in a murine tumor model.
Main Results:
- PheoA-PEI/OVA nanoparticles showed increased endocytosis and ROS generation in dendritic cells.
- Light stimulation significantly enhanced cytosolic antigen release and cross-presentation of antigens.
- In vivo studies demonstrated increased CD8+ T cell infiltration in tumors and significant tumor growth inhibition.
Conclusions:
- Light-responsive nanoparticles combined with PCI effectively enhance antigen-specific CD8+ T cell immune responses.
- This nanoparticle-based vaccine delivery system shows promise for cancer immunotherapy.
- The developed system offers a novel strategy for improving the efficacy of cancer vaccines.
